226 related articles for article (PubMed ID: 19836489)
1. Molecular markers in thyroid cancer diagnostics.
Kato MA; Fahey TJ
Surg Clin North Am; 2009 Oct; 89(5):1139-55. PubMed ID: 19836489
[TBL] [Abstract][Full Text] [Related]
2. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application.
Saggiorato E; De Pompa R; Volante M; Cappia S; Arecco F; Dei Tos AP; Orlandi F; Papotti M
Endocr Relat Cancer; 2005 Jun; 12(2):305-17. PubMed ID: 15947105
[TBL] [Abstract][Full Text] [Related]
3. The molecular diagnosis and management of thyroid neoplasms.
Theoharis C; Roman S; Sosa JA
Curr Opin Oncol; 2012 Jan; 24(1):35-41. PubMed ID: 22123232
[TBL] [Abstract][Full Text] [Related]
4. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.
Nikiforov YE; Steward DL; Robinson-Smith TM; Haugen BR; Klopper JP; Zhu Z; Fagin JA; Falciglia M; Weber K; Nikiforova MN
J Clin Endocrinol Metab; 2009 Jun; 94(6):2092-8. PubMed ID: 19318445
[TBL] [Abstract][Full Text] [Related]
5. Cytologic and molecular diagnosis of thyroid cancers: is it time for routine reflex testing?
Hassell LA; Gillies EM; Dunn ST
Cancer Cytopathol; 2012 Feb; 120(1):7-17. PubMed ID: 21882358
[TBL] [Abstract][Full Text] [Related]
6. Molecular diagnostic methods in the diagnosis and follow-up of well-differentiated thyroid carcinoma.
Rodrigo JP; Rinaldo A; Devaney KO; Shaha AR; Ferlito A
Head Neck; 2006 Nov; 28(11):1032-9. PubMed ID: 16732600
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous large-needle aspiration biopsy histology of palpable thyroid nodules: technical and diagnostic performance.
Carpi A; Nicolini A; Marchetti C; Iervasi G; Antonelli A; Carpi F
Histopathology; 2007 Aug; 51(2):249-57. PubMed ID: 17650219
[TBL] [Abstract][Full Text] [Related]
8. Recent developments in the clinical application of thyroid cancer biomarkers.
Shibru D; Chung KW; Kebebew E
Curr Opin Oncol; 2008 Jan; 20(1):13-8. PubMed ID: 18043251
[TBL] [Abstract][Full Text] [Related]
9. Ruling in or ruling out thyroid malignancy by molecular diagnostics of thyroid nodules.
Eszlinger M; Hegedüs L; Paschke R
Best Pract Res Clin Endocrinol Metab; 2014 Aug; 28(4):545-57. PubMed ID: 25047205
[TBL] [Abstract][Full Text] [Related]
10. Circulating thyroid cancer markers.
Gupta M; Chia SY
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):383-8. PubMed ID: 17940468
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathology and thyroid FNA.
Poller DN; Glaysher S
Cytopathology; 2017 Dec; 28(6):475-481. PubMed ID: 29165888
[TBL] [Abstract][Full Text] [Related]
12. Recent developments in predicting thyroid malignancy.
Stang MT; Carty SE
Curr Opin Oncol; 2009 Jan; 21(1):11-7. PubMed ID: 19125013
[TBL] [Abstract][Full Text] [Related]
13. Atypical thyroid nodules express both HBME-1 and Galectin-3, two phenotypic markers of papillary thyroid carcinoma.
Coli A; Bigotti G; Parente P; Federico F; Castri F; Massi G
J Exp Clin Cancer Res; 2007 Jun; 26(2):221-7. PubMed ID: 17725102
[TBL] [Abstract][Full Text] [Related]
14. Thyroid fine needle aspiration: how to improve clinicians' confidence and performance with the technique.
Carpi A; Di Coscio G; Iervasi G; Antonelli A; Mechanick J; Sciacchitano S; Nicolini A
Cancer Lett; 2008 Jun; 264(2):163-71. PubMed ID: 18384937
[TBL] [Abstract][Full Text] [Related]
15. [Cellular tumor markers in thyroid cancer].
Kopczyńska E; Kwapisz J; Junik R; Tyrakowski T
Pol Merkur Lekarski; 2007 Apr; 22(130):295-9. PubMed ID: 17684930
[TBL] [Abstract][Full Text] [Related]
16. Thyroid tumor marker genomics and proteomics: diagnostic and clinical implications.
Carpi A; Mechanick JI; Saussez S; Nicolini A
J Cell Physiol; 2010 Sep; 224(3):612-9. PubMed ID: 20578236
[TBL] [Abstract][Full Text] [Related]
17. Thyroid aspiration cytology: current status.
Layfield LJ; Cibas ES; Gharib H; Mandel SJ
CA Cancer J Clin; 2009; 59(2):99-110. PubMed ID: 19278960
[TBL] [Abstract][Full Text] [Related]
18. Thyroid cytology: challenges in the pursuit of low-grade malignancies.
Ohori NP; Schoedel KE
Radiol Clin North Am; 2011 May; 49(3):435-51, v-vi. PubMed ID: 21569903
[TBL] [Abstract][Full Text] [Related]
19. Molecular classification and biomarker discovery in papillary thyroid carcinoma.
Sheils O
Expert Rev Mol Diagn; 2005 Nov; 5(6):927-46. PubMed ID: 16255634
[TBL] [Abstract][Full Text] [Related]
20. Unusual thyroid tumors: a review of pathologic and molecular diagnosis.
Hunt JL
Expert Rev Mol Diagn; 2005 Sep; 5(5):725-34. PubMed ID: 16149875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
